Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Legend Biotech (LGND) added ~26% in the morning hours on Tuesday after announcing initial results from an early-stage trial for LB2501, its in vivo CAR-T cell therapy targeting B-cell non-Hodgkin ...
BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech or the Company), a global leader in cell therapy, today announced first-in-human clinical ...
** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** If you make a short list of the ...
It's taken some grinding but you're finally here, ready to claim your gold wristband and ascend to Horizon Legend status. While you may think that this marks the end of your journey across Japan in ...
Italy awarded a €211 million ($249 million) grant to a company seeking to speed up processing at artificial intelligence data centers as part of a bid to support local startups. 2D Photonics Group’s ...
The singer had been repped by Ty Stiklorius, who said in a statement that she would "continue to be John’s partner in the many for-profit and non-profit ventures we built together." By Ethan Millman ...
NVIDIA's DLSS 5 has proven to be one of the more controversial announcements so far this year. When initially announced, NVIDIA CEO Jensen Huang said it was using new "neural rendering" techniques and ...
Connecting the dots: Early reactions to Nvidia's DLSS 5 were swift and skeptical, with some observers likening the technology to an Instagram-style filter applied over gameplay footage. Nvidia CEO ...
In 1987, Gene Roddenberry somehow managed to find a cast that was as watchable and loaded with the same level of chemistry as the original "Star Trek" for "Star Trek: The Next Generation." Patrick ...
Sign of the times: An AI agent autonomously wrote and published a personalized attack article against an open-source software maintainer after he rejected its code contribution. It might be the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results